Get started
INVESCO MARKETS PLII

INVESCO MARKETS PL

No trades
See on Supercharts
Overview
Analysis
Holdings News Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪206.40 M‬ CHF
Fund flows (1Y)
‪−63.21 M‬ CHF
Dividend yield (indicated)
—
Discount/Premium to NAV
1.001%
Shares outstanding
‪4.98 M‬
Expense ratio
0.40%

About INVESCO MARKETS PL


Issuer
Invesco Ltd
Brand
Invesco
Home page
etf.invesco.com
Inception date
Nov 6, 2014
Structure
Irish VCIC
Index tracked
NASDAQ / Biotechnology
Replication method
Synthetic
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
Invesco Investment Management Ltd.
ISIN
IE00BQ70R696
The Fund is a passively managed Exchange-Traded Fund (ETF), which aims to track the Total Return performance of the NASDAQ Biotechnology Index (the Index) 1, less fees, expenses and transaction costs.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Exchange-specific
Geography
U.S.
Weighting scheme
Market cap
Selection criteria
NASDAQ - listed

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of May 14, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks100.00%
Health Technology96.86%
Technology Services1.27%
Commercial Services1.21%
Health Services0.64%
Process Industries0.02%
Bonds, Cash & Other0.00%
Miscellaneous0.00%
Cash−0.00%
Stock breakdown by region
0%83%15%0.4%
North America83.78%
Europe15.80%
Asia0.37%
Oceania0.05%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows